Works matching IS 08876924 AND DT 2013 AND VI 27 AND IP 10

Results: 35

[gamma]-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation.

Published in:

2013

By:

Morgan, R G;
Liddiard, K;
Pearn, L;
Pumford, S L;
Burnett, A K;
Darley, R L;
Tonks, A

Publication type:

Journal Article

Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study.

Published in:

2013

By:

Jovanovic, J V;
Ivey, A;
Vannucchi, A M;
Lippert, E;
Oppliger Leibundgut, E;
Cassinat, B;
Pallisgaard, N;
Maroc, N;
Hermouet, S;
Nickless, G;
Guglielmelli, P;
van der Reijden, B A;
Jansen, J H;
Alpermann, T;
Schnittger, S;
Bench, A;
Tobal, K;
Wilkins, B;
Cuthill, K;
McLornan, D

Publication type:

journal article

mTOR regulates DNA damage response through NF-κB-mediated FANCD2 pathway in hematopoietic cells.

Published in:

2013

By:

Guo, F;
Li, J;
Du, W;
Zhang, S;
O'Connor, M;
Thomas, G;
Kozma, S;
Zingarelli, B;
Pang, Q;
Zheng, Y

Publication type:

journal article

The eukaryotic translation initiation factor eIF4E is a direct transcriptional target of NF-κB and is aberrantly regulated in acute myeloid leukemia.

Published in:

2013

By:

Hariri, F;
Arguello, M;
Volpon, L;
Culjkovic-Kraljacic, B;
Nielsen, T H;
Hiscott, J;
Mann, K K;
Borden, K L B

Publication type:

journal article

The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo.

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 2086, doi. 10.1038/leu.2013.208

By:

Todisco, E;
Ciceri, F;
Oldani, E;
Boschini, C;
Micò, C;
VanLint, M T;
Donnini, I;
Patriarca, F;
Alessandrino, P E;
Bonifazi, F;
Arcese, W;
Barberi, W;
Marenco, P;
Terruzzi, E;
Cortelazzo, S;
Santarone, S;
Proia, A;
Corradini, P;
Tagliaferri, E;
Falcioni, S

Publication type:

Article

Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes.

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 1981, doi. 10.1038/leu.2013.178

By:

Mathis, S;
Chapuis, N;
Debord, C;
Rouquette, A;
Radford-Weiss, I;
Park, S;
Dreyfus, F;
Lacombe, C;
Béné, M C;
Kosmider, O;
Fontenay, M;
Bardet, V

Publication type:

Article

γ-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation.

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 2096, doi. 10.1038/leu.2013.96

By:

Morgan, R G;
Liddiard, K;
Pearn, L;
Pumford, S L;
Burnett, A K;
Darley, R L;
Tonks, A

Publication type:

Article

CX-4945, a selective inhibitor of casein kinase-2 (CK2), exhibits anti-tumor activity in hematologic malignancies including enhanced activity in chronic lymphocytic leukemia when combined with fludarabine and inhibitors of the B-cell receptor pathway.

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 2094, doi. 10.1038/leu.2013.228

By:

Prins, R C;
Burke, R T;
Tyner, J W;
Druker, B J;
Loriaux, M M;
Spurgeon, S E

Publication type:

Article

A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 2023, doi. 10.1038/leu.2013.181

By:

Metzeler, K H;
Maharry, K;
Kohlschmidt, J;
Volinia, S;
Mrózek, K;
Becker, H;
Nicolet, D;
Whitman, S P;
Mendler, J H;
Schwind, S;
Eisfeld, A-K;
Wu, Y-Z;
Powell, B L;
Carter, T H;
Wetzler, M;
Kolitz, J E;
Baer, M R;
Carroll, A J;
Stone, R M;
Caligiuri, M A

Publication type:

Article

Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 2062, doi. 10.1038/leu.2013.143

By:

Srivastava, G;
Rana, V;
Lacy, M Q;
Buadi, F K;
Hayman, S R;
Dispenzieri, A;
Gertz, M A;
Dingli, D;
Zeldenrust, S;
Russell, S;
McCurdy, A;
Kapoor, P;
Kyle, R;
Rajkumar, S V;
Kumar, S

Publication type:

Article

SETBP1 mutation analysis in 944 patients with MDS and AML.

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 2072, doi. 10.1038/leu.2013.145

By:

Thol, F;
Suchanek, K J;
Koenecke, C;
Stadler, M;
Platzbecker, U;
Thiede, C;
Schroeder, T;
Kobbe, G;
Kade, S;
Löffeld, P;
Banihosseini, S;
Bug, G;
Ottmann, O;
Hofmann, W-K;
Krauter, J;
Kröger, N;
Ganser, A;
Heuser, M

Publication type:

Article

A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control.

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 2112, doi. 10.1038/leu.2013.213

By:

Paiva, B;
Vídriales, M-B;
Rosiñol, L;
Martínez-López, J;
Mateos, M-V;
Ocio, E M;
Montalbán, M-Á;
Cordón, L;
Gutiérrez, N C;
Corchete, L;
Oriol, A;
Terol, M-J;
Echeveste, M-A;
De Paz, R;
De Arriba, F;
Palomera, L;
de la Rubia, J;
Díaz-Mediavilla, J;
Granell, M;
Gorosquieta, A

Publication type:

Article

Degree of focal immunoglobulin heavy chain locus deletion as a measure of B-cell tumor purity.

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 2067, doi. 10.1038/leu.2013.139

By:

Bergsagel, P L;
Kuehl, W M

Publication type:

Article

Early intervention with allogeneic hematopoietic cell transplantation during chemotherapy-induced aplasia in patients with high-risk acute myeloid leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 2068, doi. 10.1038/leu.2013.142

By:

Stölzel, F;
Platzbecker, U;
Mohr, B;
Röllig, C;
Middeke, J M;
Thiede, C;
Füssel, M;
Hänel, M;
Schaich, M;
Ehninger, G;
Schetelig, J;
Bornhäuser, M

Publication type:

Article

Computational dissection of distinct microRNA activity signatures associated with peripheral T cell lymphoma subtypes.

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 2107, doi. 10.1038/leu.2013.121

By:

Suzuki, H I;
Matsuyama, H;
Noguchi, M;
Yao, T;
Komatsu, N;
Mano, H;
Sugimoto, K;
Miyazono, K

Publication type:

Article

The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinib.

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 2016, doi. 10.1038/leu.2013.171

By:

Hoffmann, V S;
Baccarani, M;
Lindoerfer, D;
Castagnetti, F;
Turkina, A;
Zaritsky, A;
Hellmann, A;
Prejzner, W;
Steegmann, J-L;
Mayer, J;
Indrak, K;
Colita, A;
Rosti, G;
Pfirrmann, M

Publication type:

Article

Clonal mast cell disease not meeting WHO criteria for diagnosis of mastocytosis: clinicopathologic features and comparison with indolent mastocytosis.

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 2091, doi. 10.1038/leu.2013.227

By:

Pardanani, A;
Chen, D;
Abdelrahman, R A;
Reichard, K K;
Zblewski, D;
Wood, A J;
McClure, R F;
Butterfield, J H;
Hanson, C A;
Tefferi, A

Publication type:

Article

Bcl-xL anti-apoptotic network is dispensable for development and maintenance of CML but is required for disease progression where it represents a new therapeutic target.

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 1996, doi. 10.1038/leu.2013.151

By:

Harb, J G;
Neviani, P;
Chyla, B J;
Ellis, J J;
Ferenchak, G J;
Oaks, J J;
Walker, C J;
Hokland, P;
Roy, D C;
Caligiuri, M A;
Marcucci, G;
Huettner, C S;
Perrotti, D

Publication type:

Article

Reduced CXCR4 expression is associated with extramedullary disease in a mouse model of myeloma and predicts poor survival in multiple myeloma patients treated with bortezomib.

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 2075, doi. 10.1038/leu.2013.148

By:

Stessman, H A F;
Mansoor, A;
Zhan, F;
Janz, S;
Linden, M A;
Baughn, L B;
Van Ness, B

Publication type:

Article

Baseline differential blood count and prognosis in CD20-positive post-transplant lymphoproliferative disorder in the prospective PTLD-1 trial.

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 2102, doi. 10.1038/leu.2013.110

By:

Zimmermann, H;
Choquet, S;
Moore, J;
Salles, G;
Morschhauser, F;
Lamy, T;
Jaccard, A;
Horst, H A;
Leithäuser, M;
Dührsen, U;
Reinke, P;
Lebranchu, Y;
Neuhaus, R;
Lehmkuhl, H;
Tarella, C;
Schlattmann, P;
Riess, H;
Leblond, V;
Trappe, R U

Publication type:

Article

Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes.

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 2112, doi. 10.1038/leu.2013.229

By:

Patnaik, M M;
Padron, E;
LaBorde, R R;
Lasho, T L;
Finke, C M;
Hanson, C A;
Hodnefield, J M;
Knudson, R A;
Ketterling, R P;
Al-kali, A;
Pardanani, A;
Ali, N A;
Komrokji, R S;
Tefferi, A

Publication type:

Article

Elevated C-reactive protein is associated with shortened leukemia-free survival in patients with myelofibrosis.

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 2084, doi. 10.1038/leu.2013.207

By:

Barbui, T;
Carobbio, A;
Finazzi, G;
Guglielmelli, P;
Salmoiraghi, S;
Rosti, V;
Rambaldi, A;
Vannucchi, A M;
Barosi, G

Publication type:

Article

Problems and pitfalls regarding WHO-defined diagnosis of early/prefibrotic primary myelofibrosis versus essential thrombocythemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 1953, doi. 10.1038/leu.2013.74

By:

Barbui, T;
Thiele, J;
Vannucchi, A M;
Tefferi, A

Publication type:

Article

SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML.

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 2100, doi. 10.1038/leu.2013.97

By:

Laborde, R R;
Patnaik, M M;
Lasho, T L;
Finke, C M;
Hanson, C A;
Knudson, R A;
Ketterling, R P;
Pardanani, A;
Tefferi, A

Publication type:

Article

Dynamic acquisition of FLT3 or RAS alterations drive a subset of patients with lower risk MDS to secondary AML.

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 2081, doi. 10.1038/leu.2013.165

By:

Takahashi, K;
Jabbour, E;
Wang, X;
Luthra, R;
Bueso-Ramos, C;
Patel, K;
Pierce, S;
Yang, H;
Wei, Y;
Daver, N;
Faderl, S;
Ravandi, F;
Estrov, Z;
Cortes, J;
Kantarjian, H;
Garcia-Manero, G

Publication type:

Article

Review of health-related quality of life data in multiple myeloma patients treated with novel agents.

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 1959, doi. 10.1038/leu.2013.185

By:

Sonneveld, P;
Verelst, S G;
Lewis, P;
Gray-Schopfer, V;
Hutchings, A;
Nixon, A;
Petrucci, M T

Publication type:

Article

Physiologic corticosterone oscillations regulate murine hematopoietic stem/progenitor cell proliferation and CXCL12 expression by bone marrow stromal progenitors.

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 2006, doi. 10.1038/leu.2013.154

By:

Kollet, O;
Vagima, Y;
D'Uva, G;
Golan, K;
Canaani, J;
Itkin, T;
Gur-Cohen, S;
Kalinkovich, A;
Caglio, G;
Medaglia, C;
Ludin, A;
Lapid, K;
Shezen, E;
Neufeld-Cohen, A;
Varol, D;
Chen, A;
Lapidot, T

Publication type:

Article

Distribution of genomic breakpoints in chronic myeloid leukemia: analysis of 308 patients.

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 2105, doi. 10.1038/leu.2013.116

By:

Ross, D M;
O'Hely, M;
Bartley, P A;
Dang, P;
Score, J;
Goyne, J M;
Sobrinho-Simoes, M;
Cross, N C P;
Melo, J V;
Speed, T P;
Hughes, T P;
Morley, A A

Publication type:

Article

The eukaryotic translation initiation factor eIF4E is a direct transcriptional target of NF-κB and is aberrantly regulated in acute myeloid leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 2047, doi. 10.1038/leu.2013.73

By:

Hariri, F;
Arguello, M;
Volpon, L;
Culjkovic-Kraljacic, B;
Nielsen, T H;
Hiscott, J;
Mann, K K;
Borden, K L B

Publication type:

Article

Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 2032, doi. 10.1038/leu.2013.219

By:

Jovanovic, J V;
Ivey, A;
Vannucchi, A M;
Lippert, E;
Oppliger Leibundgut, E;
Cassinat, B;
Pallisgaard, N;
Maroc, N;
Hermouet, S;
Nickless, G;
Guglielmelli, P;
van der Reijden, B A;
Jansen, J H;
Alpermann, T;
Schnittger, S;
Bench, A;
Tobal, K;
Wilkins, B;
Cuthill, K;
McLornan, D

Publication type:

Article

Monosomal karyotype in MDS: explaining the poor prognosis?

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 1988, doi. 10.1038/leu.2013.187

By:

Schanz, J;
Tüchler, H;
Solé, F;
Mallo, M;
Luño, E;
Cervera, J;
Grau, J;
Hildebrandt, B;
Slovak, M L;
Ohyashiki, K;
Steidl, C;
Fonatsch, C;
Pfeilstöcker, M;
Nösslinger, T;
Valent, P;
Giagounidis, A;
Aul, C;
Lübbert, M;
Stauder, R;
Krieger, O

Publication type:

Article

A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control.

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 2056, doi. 10.1038/leu.2013.166

By:

Paiva, B;
Vídriales, M-B;
Rosiñol, L;
Martínez-López, J;
Mateos, M-V;
Ocio, E M;
Montalbán, M-Á;
Cordón, L;
Gutiérrez, N C;
Corchete, L;
Oriol, A;
Terol, M-J;
Echeveste, M-A;
De Paz, R;
De Arriba, F;
Palomera, L;
de la Rubia, J;
Díaz-Mediavilla, J;
Granell, M;
Gorosquieta, A

Publication type:

Article

Role of cysteine 288 in nucleophosmin cytoplasmic mutations: sensitization to toxicity induced by arsenic trioxide and bortezomib.

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 1970, doi. 10.1038/leu.2013.222

By:

Huang, M;
Thomas, D;
Li, M X;
Feng, W;
Chan, S M;
Majeti, R;
Mitchell, B S

Publication type:

Article

mTOR regulates DNA damage response through NF-κB-mediated FANCD2 pathway in hematopoietic cells.

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 2040, doi. 10.1038/leu.2013.93

By:

Guo, F;
Li, J;
Du, W;
Zhang, S;
O'Connor, M;
Thomas, G;
Kozma, S;
Zingarelli, B;
Pang, Q;
Zheng, Y

Publication type:

Article

NRAS mutations with low allele burden have independent prognostic significance for patients with lower risk myelodysplastic syndromes.

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 2077, doi. 10.1038/leu.2013.160

By:

Murphy, D M;
Bejar, R;
Stevenson, K;
Neuberg, D;
Shi, Y;
Cubrich, C;
Richardson, K;
Eastlake, P;
Garcia-Manero, G;
Kantarjian, H;
Ebert, B L;
Mike Makrigiorgos, G

Publication type:

Article